New cancer clinical trial: A Study of SHR6390 + Letrozole for First-Line Treatment of Postmenopausal Women With HR+/HER2- Advanced Breast Cancer

Published on: March 29, 2018 at 12:00PM
Condition:   Advanced Breast Cancer
Interventions:   Drug: SHR6390;   Drug: Letrozole
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2EafMRb